@pulsedelectricc
ID: 1520242342019702784
calendar_today30-04-2022 03:23:24
2 Tweet
46 Followers
1,1K Following
5 years ago
Gala Therapeutics Receives FDA Approval to Commence Pivotal Trial to Evaluate the RheOx™ System for Chronic Bronchitis prnewswire.com/news-releases/…
3 years ago
Explore OPDIVO + Chemo, the first & only neoadjuvant immunotherapy combination in resectable NSCLC. See Full Prescribing Info: bit.ly/OpdivoPI